Viagra May Help Prevent Diabetes: Study
WASHINGTON: The anti-impotence drug Viagra may help ward off type 2 diabetes in people at risk for the disorder by improving their insulin sensitivity, a new study has claimed.
The drug , sold as Viagra and other brand names, improves insulin sensitivity in people at risk for diabetes, researchers said.
Sildenafil inhibits an enzyme called phosphodiesterase 5 (PDE5), resulting in relaxation of smooth muscle, vasodilation and increased blood flow. Sildenafil is used to treat erectile dysfunction and pulmonary arterial hypertension.
Animal studies suggest that sildenafil also can improve insulin sensitivity, the uptake of glucose from the bloodstream by muscle.
This action can lower the level of circulating glucose, and potentially reduce the risk of diabetes, researchers said.
In the current study by researchers at Vanderbilt University Medical Centre in US, overweight individuals with prediabetes were randomly assigned to receive sildenafil or placebo (inactive drug) for three months.
Of the 42 subjects who completed the study, those treated with sildenafil were significantly more sensitive to insulin, the researchers said.
While further studies are needed to determine whether long-term treatment can prevent the onset of diabetes in high-risk patients, "sildenafil and related drugs could offer a potential avenue for addressing the rising number of diabetes diagnoses," said Nancy J Brown, chair of the Department of Medicine at Vanderbilt.
According to the Endocrine Society, more than 26 million Americans have been diagnosed with type 2 diabetes, in which the body's tissues are resistant to insulin, researchers said.
Incidence of the disease, which is associated with obesity, is growing rapidly, they said.
Weight loss and exercise regimens are difficult for many people, and some current medications aimed at preventing diabetes are limited by concerns about adverse effects, Brown said.
Sildenafil and related drugs prevent PDE5 from breaking down a chemical in the body called cyclic GMP, which relaxes blood vessels and increases insulin sensitivity, the researchers said.
The drug , sold as Viagra and other brand names, improves insulin sensitivity in people at risk for diabetes, researchers said.
Sildenafil inhibits an enzyme called phosphodiesterase 5 (PDE5), resulting in relaxation of smooth muscle, vasodilation and increased blood flow. Sildenafil is used to treat erectile dysfunction and pulmonary arterial hypertension.
Animal studies suggest that sildenafil also can improve insulin sensitivity, the uptake of glucose from the bloodstream by muscle.
This action can lower the level of circulating glucose, and potentially reduce the risk of diabetes, researchers said.
In the current study by researchers at Vanderbilt University Medical Centre in US, overweight individuals with prediabetes were randomly assigned to receive sildenafil or placebo (inactive drug) for three months.
Of the 42 subjects who completed the study, those treated with sildenafil were significantly more sensitive to insulin, the researchers said.
While further studies are needed to determine whether long-term treatment can prevent the onset of diabetes in high-risk patients, "sildenafil and related drugs could offer a potential avenue for addressing the rising number of diabetes diagnoses," said Nancy J Brown, chair of the Department of Medicine at Vanderbilt.
According to the Endocrine Society, more than 26 million Americans have been diagnosed with type 2 diabetes, in which the body's tissues are resistant to insulin, researchers said.
Incidence of the disease, which is associated with obesity, is growing rapidly, they said.
Weight loss and exercise regimens are difficult for many people, and some current medications aimed at preventing diabetes are limited by concerns about adverse effects, Brown said.
Sildenafil and related drugs prevent PDE5 from breaking down a chemical in the body called cyclic GMP, which relaxes blood vessels and increases insulin sensitivity, the researchers said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.